Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

Quick Launch

WILLIAM R. LOMBARDI, MD, FACC, FSCAI

Director for Complex Coronary Artery Disease Therapies
Clinical Associate Professor, Division of Cardiology
University of Washington Medical Center
 
 
1959 N.E. Pacific Street
Box 356340
Seattle, WA 98195-347430
 
 
 
 
 

EDUCATION AND TRAINING

  • BS, Biology, Willamette University, Salem, Oregon, 1986-1990
  • MD, Tulane Medical School, New Orleans, Louisiana, 1990-1994 
  • Internal Medicine Residency, University of Utah, Salt Lake City, Utah, 1994-1997
  • Interventional Cardiology Fellowship, University of Utah, LDS Hospital, Salt Lake City, Utah, 2000-2001
 

BOARD CERTIFICATION

  • Internal Medicine, American Board of Internal Medicine, 1999-2009
  • Cardiovascular Disease, American Board of Internal Medicine, 2000, 2020
  • Interventional Cardiology, American Board of Internal Medicine, 2001- 2021

 

AREAS ​OF CLINICAL EXPERTISE

  •  

 

SPECIAL ACCOMPLISHMENTS

  •  Dean's List, Willamette University, Salem, Oregon
  •  Kemal Akdamar MD Memorial Award for Scholarhip in Gastroenterology, Tulane Medical School, New Orleans, Louisiana

 

CURRENT RESEARCH INTERESTS

 

 Selected Publications

 
 
Hermiller JB, Rutledge DR, Mao VW, Shao W, Wang J, Gruberg L, Lombardi WL, Sharma SK, Krucoff MW. Clinical outcomes in real-world pateitns with small vessel disease treated with Xience V Everolimus Eluting Stents: one year results from the Xience V USA condition of approval post-market study. CCI in press 2014.
 
 
Spratt JC, Lombardi WL. Forward: Chronic Total Occlusion Percutaneous Coronary Intervention as Mainstream Therapy: are We at a Tipping Point?. Interventional Cardiology Oct 2013 Vol 5. No 5: 481-483.
 
 
Christopoulos G, Menon RV, Karmpaliotis D, Alaswad K, Lombardi WL, Grantham JG, Michael TT, Patel VG, Rangan BV, Kotsia AP, Lembo N, Kandzari DE, Lee J, Kalynych A, Carlson H, Garcia S, Banerjee S, Thompson CA, Brilakis ES. Application of the “Hybrid Approach” to Chronic Total Occlusions in Patients with Prior Coraonary Artery Bypass Graft Surgery (From a Contemporary Multicenter US Registry). American Journal of Cardiology 2014 in press.
 
 
Michael TT, Karmpaliotis D, Brilakis ES, Mohammed Alomar, Abdullah SM, Kirkland BL, Mishoe KL, Lembo N,Kalynych A, Carlson H, Banerjee S, Luna M, Lombardi W, Kandzari DE. Temporal Trends of Fluoroscopy time and Contrast Utilization in Coronary Chronic Total Occlusion Revascularization: Insight from a Multicenter United States Registry. CCI in press. 2014.
 
 
Karmpaliotis D, Lembo N, Kalynych A, Carlson H, Lombardi WL, Anderson CN, Rinehart S, Kirkland B, Shemwell KC, Kandzari DE. Development of a High-Volume, Multiple-Operator Program for Percutaneous Chronic Total Coronary Occlusion Revascularization: Procedural, Clinical, and Cost-Utilization Outcomes. 2013 July 1 Vol 82 No 1: 1-8.